enrofloxacin
A fluoroquinolone antibiotic, similar to ciprofloxacin, useful against a wide spectrum of aerobic bacteria, but particularly gram-negative bacteria and mycoplasma. Marketed for veterinary use only as Baytril.
|
Results for Enrofloxacin
|
On this page:
|
A fluoroquinolone antibiotic, similar to ciprofloxacin, useful against a wide spectrum of aerobic bacteria, but particularly gram-negative bacteria and mycoplasma. Marketed for veterinary use only as Baytril.
Enrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. Enrofloxacin is currently FDA-approved for treatment of individual pets and domestic animals in the United States. In September of 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium Campylobacter, a human pathogen.[1] Fluoroquinolones such as ciprofloxacin are widely used in the treatment of human disease.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Join the WikiAnswers Q&A community. Post a question or answer questions about "Enrofloxacin" at WikiAnswers.
Copyrights:
![]() | Veterinary Dictionary. Saunders Comprehensive Veterinary Dictionary 3rd Edition. Copyright © 2007 by D.C. Blood, V.P. Studdert and C.C. Gay, Elsevier. All rights reserved. Read more | |
![]() | Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Enrofloxacin". Read more |